Literature DB >> 28284380

Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease.

Mark A Perazella1.   

Abstract

Tubulointerstitial diseases are a relatively common cause of acute and/or chronic kidney disease. Acute tubulointerstitial nephritis (ATIN) most commonly develops in patients exposed to various medications; however, it can occur from infections, autoimmune and systemic diseases, environmental exposures, and some idiopathic causes. Chronic tubulointerstitial nephritis may develop in patients with previous ATIN or may be the initial manifestation of an autoimmune, systemic, environmental, or metabolic process. It can be challenging for clinicians to differentiate the various causes of acute and chronic kidney disease. In particular, distinguishing ATIN from other causes of acute kidney injury, such as acute tubular necrosis or a rapidly progressive glomerulonephritis, is important as treatment and prognosis are often quite different. To this end, clinicians use clinical assessment, certain laboratory data, and various imaging tests to make a diagnosis. Unfortunately, most of these tests are insufficient for this purpose. As a result, kidney biopsy is often required to accurately diagnose ATIN and guide management. For chronic tubulointerstitial nephritis, kidney biopsy is needed less often as available therapies for this entity, with a few exceptions, are limited and primarily supportive.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Acute tubulointerstitial nephritis; Chronic tubulointerstitial nephritis; Tubulointerstitial disease; Urine microscopy

Mesh:

Substances:

Year:  2017        PMID: 28284380     DOI: 10.1053/j.ackd.2016.08.003

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  15 in total

1.  Intravital imaging of the kidney in a rat model of salt-sensitive hypertension.

Authors:  Bradley T Endres; Ruben M Sandoval; George J Rhodes; Silvia B Campos-Bilderback; Malgorzata M Kamocka; Christopher McDermott-Roe; Alexander Staruschenko; Bruce A Molitoris; Aron M Geurts; Oleg Palygin
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

2.  Treatment of Drug-Induced Acute Tubulointerstitial Nephritis: The Search for Better Evidence.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-05       Impact factor: 8.237

Review 3.  Drug-Induced Acute Interstitial Nephritis.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-11       Impact factor: 8.237

4.  Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.

Authors:  Dennis G Moledina; F Perry Wilson; Jordan S Pober; Mark A Perazella; Nikhil Singh; Randy L Luciano; Wassim Obeid; Haiqun Lin; Michael Kuperman; Gilbert W Moeckel; Michael Kashgarian; Lloyd G Cantley; Chirag R Parikh
Journal:  JCI Insight       Date:  2019-05-16

5.  Aromatase inhibition increases blood pressure and markers of renal injury in female rats.

Authors:  Rawan N Almutlaq; Annie E Newell-Fugate; Louise C Evans; Huma Fatima; Eman Y Gohar
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-28

6.  Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: PRO.

Authors:  Andrew Donati; Namrata Krishnan
Journal:  Kidney360       Date:  2022-01-20

Review 7.  Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced Nephrotoxicity.

Authors:  Xiao Wei; Jun Yu; Zhengkun Xu; Chun Wang; Yonggui Wu
Journal:  Drug Saf       Date:  2022-06-01       Impact factor: 5.228

8.  Activation of G protein-coupled estrogen receptor 1 ameliorates proximal tubular injury and proteinuria in Dahl salt-sensitive female rats.

Authors:  Eman Y Gohar; Rawan N Almutlaq; Elizabeth M Daugherty; Maryam K Butt; Chunhua Jin; Jennifer S Pollock; David M Pollock; Carmen De Miguel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-01-06       Impact factor: 3.619

Review 9.  New Biomarkers in Acute Tubulointerstitial Nephritis: A Novel Approach to a Classic Condition.

Authors:  Laura Martinez Valenzuela; Juliana Draibe; Xavier Fulladosa; Juan Torras
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

10.  Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.

Authors:  Haoran Liu; Xiaoqi Yang; Kun Tang; Tao Ye; Chen Duan; Peng Lv; Libin Yan; Xiaoliang Wu; Zhiqiang Chen; Jianhe Liu; Yaoliang Deng; Guohua Zeng; Jinchun Xing; Zhangqun Ye; Hua Xu
Journal:  Theranostics       Date:  2020-06-05       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.